BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15492837)

  • 1. p16INK4a polymorphism: associations with tumour progression in patients with sporadic colorectal cancer.
    McCloud JM; Sivakumar R; Greenhough A; Elder J; Jones PW; Deakin M; Elder JB; Fryer AA; Hoban PR
    Int J Oncol; 2004 Nov; 25(5):1447-52. PubMed ID: 15492837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer.
    Holley SL; Rajagopal R; Hoban PR; Deakin M; Fawole AS; Elder JB; Elder J; Smith V; Strange RC; Fryer AA
    Int J Oncol; 2006 Jan; 28(1):231-6. PubMed ID: 16328000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
    Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
    Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
    Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer.
    Rajagopal R; Deakin M; Fawole AS; Elder JB; Elder J; Smith V; Strange RC; Fryer AA
    Carcinogenesis; 2005 Dec; 26(12):2157-63. PubMed ID: 16051638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
    Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
    Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer.
    Shin Y; Kim IJ; Kang HC; Park JH; Park HW; Jang SG; Lee MR; Jeong SY; Chang HJ; Ku JL; Park JG
    Carcinogenesis; 2004 Nov; 25(11):2173-6. PubMed ID: 15231691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
    Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
    World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
    Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
    Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis.
    Watson MA; Gay L; Stebbings WS; Speakman CT; Bingham SA; Loktionov A
    Clin Sci (Lond); 2003 May; 104(5):537-45. PubMed ID: 12529167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
    Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
    J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
    Dimberg J; Hugander A; Löfgren S; Wågsäter D
    Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
    BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
    Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
    Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer.
    Przybylowska K; Smolarczyk K; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):569-72. PubMed ID: 11876553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer.
    Viet HT; Wågsäter D; Hugander A; Dimberg J
    Oncol Rep; 2005 Oct; 14(4):915-8. PubMed ID: 16142351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.
    Cacev T; Radosević S; Krizanac S; Kapitanović S
    Carcinogenesis; 2008 Aug; 29(8):1572-80. PubMed ID: 18628251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
    Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH
    Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygosity for interleukin-18 -607 A/C polymorphism is associated with risk for colorectal cancer.
    Nikiteas N; Yannopoulos A; Chatzitheofylaktou A; Tsigris C
    Anticancer Res; 2007; 27(6B):3849-53. PubMed ID: 18225542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.